IPSC - Century Therapeutics, Inc.

QQQ $ 622.38 $ 4.94 (0.8 %)

DIA $ 473.04 $ 2.23 (0.47 %)

SPY $ 677.28 $ 2.47 (0.37 %)

TLT $ 89.01 $ -0.57 (-0.64 %)

GLD $ 365.20 $ 0.10 (0.03 %)

Previous Close

$ 0.5598

Open

$ 0.58

Bid

$ 0.55 x 2,500

Ask

$ 0.61 x 1,750

Day's Range

$ 0.55 - $ 0.58

52 Week Range

$ 0.34 - $ 1.83

Volume

1,337,408

Average Volume

Market Cap

48.36M

Beta (5Y Monthly)

$ 1.36

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	03-19-2025	12-31-2024	10-K
4	11-05-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-14-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-16-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-16-2022	03-31-2022	10-Q
15	03-17-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Century Therapeuics Appoints Brent Pfeiffe...
08/14/2025 20:59:57

Century Therapeutics Q2 EPS $(0.38) Misses...
08/14/2025 20:26:03

Century Therapeutics Files For Mixed Shelf...
07/10/2025 20:58:30

- SEC Filing

Chardan Capital Maintains Buy on Century T...
05/16/2025 22:33:52

Chardan Capital analyst Geulah Livshits maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target ...

Century Therapeutics Q1 EPS $0.89 Beats $0...
05/15/2025 20:16:26

Century Therapeutics (NASDAQ:IPSC) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of ...

12 Health Care Stocks Moving In Wednesday'...
04/16/2025 12:07:22

HC Wainwright & Co. Maintains Buy on Centu...
04/03/2025 10:59:41

HC Wainwright & Co. analyst Mitchell Kapoor maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
03/28/2025 21:05:46

Guggenheim Reiterates Buy on Century Thera...
03/28/2025 14:43:23

Guggenheim analyst Kelsey Goodwin reiterates Century Therapeutics (NASDAQ:IPSC) from Buy to Buy.

carnival-to-rally-around-48-here-are-10-top-analyst-forecasts-for-monday

Carnival To Rally Around 48%? Here Are 10 ...
03/24/2025 12:48:18

Chardan Capital Maintains Buy on Century T...
03/24/2025 12:07:01

Chardan Capital analyst Geulah Livshits maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target ...

Demystifying Century Therapeutics: Insight...
03/21/2025 14:01:08

Guggenheim Maintains Buy on Century Therap...
03/21/2025 13:55:07

Guggenheim analyst Kelsey Goodwin maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target from $...

Piper Sandler Maintains Overweight on Cent...
03/20/2025 16:37:49

Piper Sandler analyst Edward Tenthoff maintains Century Therapeutics (NASDAQ:IPSC) with a Overweight and lowers the price ta...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
03/19/2025 21:06:24

Century Therapeutics FY24 EPS $(1.61) Up F...
03/19/2025 20:04:23

Century Therapeutics Announces Preclinical...
03/19/2025 20:03:37

Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CN...

Century Therapeutics Shares Halted, News P...
03/19/2025 20:02:22

Century Therapeutics Receives Nasdaq Notic...
02/28/2025 21:22:15

- SEC Filing

Guggenheim Reiterates Buy on Century Thera...
01/22/2025 15:49:33

Guggenheim analyst Michael Schmidt reiterates Century Therapeutics (NASDAQ:IPSC) from Buy to Buy.